
Hematologist-Oncologist

No OPD information available
Acute Lymphoblastic Leukemia (ALL)
Chronic Myelogenous Leukemia (CML)
Leukemia
Acute Myeloid Leukemia (AML)
B-Cell Lymphoma
Burkitt Lymphoma
Chromosome 7p Deletion
Down Syndrome
Hypereosinophilic Syndrome
L1 Syndrome
Non-Hodgkin Lymphoma
Splenomegaly
Deborah L. White is a female medical professional who specializes in treating different types of blood cancers and related conditions like leukemia, lymphoma, and genetic disorders. She helps patients with Acute Lymphoblastic Leukemia (ALL), Chronic Myelogenous Leukemia (CML), Acute Myeloid Leukemia (AML), B-Cell Lymphoma, Burkitt Lymphoma, and other conditions like Down Syndrome and Splenomegaly.
Deborah L. White uses special skills and treatments to help her patients fight these diseases. She is known for her expertise in understanding complex genetic rearrangements in leukemia and developing effective detection strategies. Patients trust her because she communicates clearly, listens to their concerns, and explains treatment options in a way they can understand.
To stay updated with the latest medical knowledge and research, Deborah L. White regularly attends conferences, reads scientific journals, and collaborates with other experts in the field. She values teamwork and has good relationships with her colleagues, working together to provide the best care for their patients.
Deborah L. White's work has had a positive impact on many patients' lives. Her research on deciphering genetic complexities in leukemia has led to better detection methods and more targeted treatments, improving outcomes for patients with these challenging diseases.
One of her notable publications, "Deciphering IGH rearrangement complexity and detection strategies in acute lymphoblastic leukaemia," published in NPJ precision oncology, showcases her dedication to advancing the field of cancer research and improving patient care.
In summary, Deborah L. White is a compassionate and skilled medical professional who is dedicated to helping patients with blood cancers and genetic disorders. Her expertise, clear communication, commitment to staying updated with the latest research, and collaborative approach with colleagues have all contributed to her positive impact on patients' lives.
